Stealth BioTherapeutics Reports Fiscal Year 2020 Financial Results And Recent Business Highlights
BOSTON, April 6, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and...